High intrinsic apoptosis, but not radiation-induced apoptosis, predicts better survival in rectal carcinoma patients

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 2, 2003, Pages 434-443

  Marijnen, Corrie A M ^a   Nagtegaal, Iris D ^a   Mulder Stapel, Adri A ^a   Schrier, Peter I ^a   Van De Velde, Cornelis J H ^a   Van Krieken, J Han J M ^b   Peltenburg, Lucy T C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Prognosis; Proliferation; Radiotherapy; Rectal carcinoma

Indexed keywords

ANTIBODIES; CELLS; RADIOTHERAPY; TUMORS;

MALIGNANT TUMORS;

ONCOLOGY;

ADULT; AGGRESSIVENESS; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CARCINOMA CELL; CELL DEATH; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RECTUM CARCINOMA; TUMOR CELL;

EID: 0042383226     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00580-7     Document Type: Article

References (31)

1. Sobin L.H., Wittekind C.H. UICC TNM classification of malignant tumours. 5th ed:1997;John Wiley & Sons, New York. p. 66-69.
2. Meyn R.E., Stephens L.C., Ang K.K., et al. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol. 64:1993;583-591.
3. Stadelmann C., Lassmann H. Detection of apoptosis in tissue sections. Cell Tissue Res. 301:2000;19-31.
4. McMillan T.J., Steel G.G. DNA damage and cell killing. Steel G. Basic clinical radiobiology. 2nd ed:1997;58-69 Arnold, London.
5. Leers M.P., Kolgen W., Bjorklund V., et al. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol. 187:1999;567-572.
6. Heald R.J., Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1:1986;1479-1482.
7. Martling A.L., Holm T., Rutqvist L.E., et al. for the Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet. 356:2000;93-96.
8. Dahlberg M., Glimelius B., Pahlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg. 86:1999;379-384.
9. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 336:1997;980-987.
10. Kapiteijn E., Marijnen C.A.M., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 345:2001;638-646.
11. Quirke P., Durdey P., Dixon M.F., et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection Histopathological study of lateral tumour spread and surgical excision . Lancet. 2:1986;996-999.
12. Nagtegaal I.D., Marijnen C.A.M., Klein Kranenbarg E., et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma Not one but two mm is the limit . Am J Surg Pathol. 26:2002;350-357.
13. Nagtegaal I.D., Marijnen C.A.M., Klein Kranenbarg E., et al. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect on histopathological and immunohistochemical study. BMC Cancer. 1:2001;7.
14. Wheeler J.A., Stephens L.C., Tornos C., et al. ., for the American Society for Therapeutic Radiology and Oncology. ASTRO Research Fellowship Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma . Int J Radiat Oncol Biol Phys. 32:1995;1487-1493.
15. Sheridan M.T., Cooper R.A., West C.M. A high ratio of apoptosis to proliferation correlates with improved survival after radiotherapy for cervical adenocarcinoma. Int J Radiat Oncol Biol Phys. 44:1999;507-512.
16. Levine E.L., Renehan A., Gossiel R., et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol. 37:1995;1-9.
17. Langlois N.E., Lamb J., Eremin O., et al. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under Relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products . J Pathol. 182:1997;392-397.
18. Adell G.C., Zhang H., Evertsson S., et al. Apoptosis in rectal carcinoma Prognosis and recurrence after preoperative radiotherapy . Cancer. 91:2001;1870-1875.
19. Jonges L.E., Nagelkerke J.F., Ensink N.G., et al. Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest. 81:2001;681-688.
20. Schwandner O., Schiedeck T.H., Bruch H.P., et al. Apoptosis in rectal cancer Prognostic significance in comparison with clinical histopathologic, and immunohistochemical variables . Dis Colon Rectum. 43:2000;1227-1236.
21. Evertsson S., Bartik Z., Zhang H., et al. Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma. Int J Oncol. 15:1999;53-58.
22. Nagtegaal I.D., van de Velde C.J.H., van der Worp E., et al. Macroscopic evaluation of rectal cancer resection specimen Clinical significance of the pathologist in quality control . J Clin Oncol. 20:2002;1729-1734.
23. Tannapfel A., Nusslein S., Fietkau R., et al. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 41:1998;585-591.
24. Sakakura C., Koide K., Ichikawa D., et al. Analysis of histological therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, hyperthermia and 5-fluorouracil suppositories for advanced rectal cancers. Br J Cancer. 77:1998;159-166.
25. Porschen R., Lohe B., Hengels K.J., et al. Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki-67 Correlation with pathohistologic criteria and influence of irradiation . Cancer. 64:1989;2501-2505.
26. Willett C.G., Warland G., Hagan M.P., et al. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol. 13:1995;1417-1424.
27. Marijnen C.A.M., Kapiteijn E., Nagtegaal I.D., et al. p53 expression in human rectal tissue after radiotherapy upregulation in normal mucosa versus functional loss in rectal carcinomas . Int J Radiat Oncol Biol Phys. 52:2002;720-728.
28. Kyzer S., Gordon P.H. Determination of proliferative activity in colorectal carcinoma using monoclonal antibody Ki67. Dis Colon Rectum. 40:1997;322-325.
29. van Triest B., Pinedo H.M., Blaauwgeers J.L., et al. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res. 6:2000;1063-1072.
30. Adell G., Zhang H., Jansson A., et al. Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys. 50:2001;659-663.
31. Willett C.G., Warland G., Coen J., et al. Rectal cancer The influence of tumor proliferation on response to preoperative irradiation . Int J Radiat Oncol Biol Phys. 32:1995;57-61.